Shopping Cart
- Remove All
- Your shopping cart is currently empty
RBN-3143 is a potent inhibitor of NAD+-competitive catalytic PARP14 (IC50= 4 nM), which inhibits ADP-ribosylation mediated by PARP14 and stabilizes PARP14 in cell lines, demonstrating research potential for lung inflammation.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $87 | In Stock | |
5 mg | $213 | In Stock | |
10 mg | $313 | In Stock | |
25 mg | $533 | In Stock | |
50 mg | $768 | In Stock | |
100 mg | $1,080 | In Stock | |
500 mg | $2,160 | In Stock | |
1 mL x 10 mM (in DMSO) | $235 | In Stock |
Description | RBN-3143 is a potent inhibitor of NAD+-competitive catalytic PARP14 (IC50= 4 nM), which inhibits ADP-ribosylation mediated by PARP14 and stabilizes PARP14 in cell lines, demonstrating research potential for lung inflammation. |
Targets&IC50 | PARP14:4 nM |
In vivo | RBN-3143 (5 μg; Intranasal administration) can improve the steroid resistant asthma mouse model [1]. |
Molecular Weight | 449.54 |
Formula | C22H28FN3O4S |
Cas No. | 2360853-16-1 |
Smiles | CC(=O)N1CCC(COc2cc(F)c3c(c2)nc(CSC2CCOCC2)[nH]c3=O)CC1 |
Relative Density. | 1.41 g/cm3 (Predicted) |
Storage | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 11.2 mg/mL (25.0 mM), Sonication and heating to 80℃ are recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.